Oppsummering fra ERS 27. september – 1. oktober 2025
Lungehelse i et globalt perspektiv
Vi har samlet de mest spennende erfaringene fra årets internasjonale ERS-kongress i Amsterdam, hvor temaet var Respiratory Health around the world.
Hvert tredje medlem av European Respiratory Society er basert utenfor Europa, noe som gjør kongressen til en utmerket plattform for global informasjonsutveksling. Med årets tema ønsker ERS å fokusere på globale spørsmål for å redusere global urettferdighet innen lungehelse, og belyse spørsmål som er fordelaktig for lungehelsen for hele verdens befolkning.
Kan spørreskjemaer bidra til å oppdage KOLS?
Nettbasert egenvurdering kan bidra til at kols oppdages tidlig, i henhold til en norsk studie. Forskerne brukte et nettskjema med tre spørsmål for å identifisere personer med udiagnostisert kols.
Studien ble presentert på ERS og vi fikk en spesiell presentasjon som du kan se her!
Nytt fra ERS 2025
Role of biological sex in asthma and COPD
Women are more affected by asthma in adulthood and increasingly by COPD. Sex hormones influence immune responses in asthma, with estrogen and testosterone affecting inflammation through distinct receptor pathways. Should biological sex guide treatment decisions? Les mer
Redefining Remission in Severe Asthma: A New Framework
A new framework from Professor Celeste Porsbjerg’s team redefines remission in severe asthma by focusing on disease activity, not damage. Early, targeted treatment during the “at-risk asthma” phase may prevent lasting harm. Les mer
The exposome and respiratory health: key takeaways from ERS 2025
Lifelong exposure to environmental factors — especially air pollution — significantly affects the risk and progression of chronic lung diseases, and understanding these interactions is key for early intervention and personalized prevention strategies. Les mer
Fighting global threats to respiratory health
Many preventable respiratory hazards are both a cause and a consequence of climate change. Fine particulate matter, especially from wildfires and indoor sources, poses serious health risks and disproportionately affects vulnerable populations. Targeted actions—such as emission reduction, improved indoor air quality, and equity-focused interventions—are essential to protect public health. Les mer
Act before damage occurs – early disease in COPD
Some get off to a bad start, others simply do not realize they have a disease. And others fall into the mind trap of thinking that tobacco exposure could be too low to harm. Either way, to identify and treat persons living with COPD early in their disease is intriguing- and possible. Les mer
Eosinophils in COPD: part of the pattern or misclassified asthma?
Are eosinophils in COPD truly a marker of type 2 (T2) inflammation, or do they simply reflect underlying or misclassified asthma? Les mer
Improving outcomes in asthma and COPD through optimized inhaler use
Effective inhaler therapy hinges on matching the right device to the right patient—and ensuring proper technique through training. As sustainability goals evolve, clinical decisions must remain patient-centered to avoid unintended harm. Les mer
Respiratory health, comorbidities and mortality
Global leading researchers —strongly represented by the Nordics—presented compelling findings on chronic obstructive pulmonary disease (COPD) and its complex interplay with cardiovascular, metabolic, genetic, and socioeconomic factors. Les mer
Patients. Do they know enough to take control?
Do patients with greater knowledge manage their disease better? This question was addressed in a cross sectional study presented at ERS2025. Les mer
Body, mind and spirit: Lung conditions are not just somatic
Mental health is inseparable from physical treatment This was the resounding message from a recent international panel moderated by Dr. Liz Steve, a UK-based health psychologist, at the ERS Congress Les mer
Can a podcast make – or break patient engagement?
Podcasts as a tool to support patient participation in hospital consultations: An intervention study Part of the session: Psychological and behavioural dimensions of respiratory innovation Speaker Jannie Frølund (Denmark) In Les mer
Understanding impact of socioeconomic factors on respiratory health
World village session Environmental Health and Inequalities in Respiratory Health Speakers Hanna Haveri, MD, PhD – Neurologist and Planetary Health Physician (Nature Step, Finland) Liz Grant, PhD – Assistant Principal Les mer
Oppsummering fra ERS Satelittsymposium 4. mars 2025
ERS satellitt: Lungenes utvikling
Lung health starts early
The foetal lungs develop in five different stages before birth, so the timing and type of insults to this development will determine the impact. New data shows that antenatal insults may impact lung function over decades. Les mer
Preschool wheeze
Preschool wheeze is a heterogenous condition with multiple underlying pathophysiological mechanisms that result in similar clinical manifestations. Frequent severe exacerbations is linked to high risk of developing asthma. Les mer
Consequences of vaping and e-cigarette smoking in children and adolescents
Elif Dagli’s talk about e-cigarettes sparked a lot of interest in the Q&A session and it’s clear that we currently have more questions than answers on what risks are entailed and what can be done to stop the trend. Les mer
ERS Satellitt: Astma
Asthma comorbidities
In summary: Asthma is a complex disease worsened by comorbidities like CRSwNP, GERD, OSA, and obesity, which share inflammatory pathways and reduce treatment effectiveness. Obesity, in particular, exacerbates airway inflammation and poor asthma control. A treatable traits approach and multidisciplinary care can improve outcomes by targeting both pulmonary and non-pulmonary factors. Les mer
Self-management of asthma
It is essential to understand the beliefs and decisions that drive behavior and decision-making around self-management of asthma. What can influence behaviour and what does ‘Good Control’ look like for the asthma patient – how can self-management be improved? Les mer
ERS satellitt: Kols
Global burden of COPD
COPD is an increasingly important cause of morbidity, disability and mortality worldwide. Environmental risk factors are important to address for future lung health. Les mer
Are all COPD the same?
Spoiler alert: it is not! You are probably not surprised if you are meeting people living with COPD in health care. But are you aware of the pathophysiological differences behind the different faces of this disease? Les mer
Innovating in rehabilitation
Implementation is one of the greatest challenges in pulmonary rehabilitation of COPD. Innovations in rehabilitation may remove barriers to getting onboard a PR programme – and sticking to it. Les mer
Sammendrag fra ERS 7.-11. september 2024
Utviklingen av astma-KOLS går fremover og kolleger fra medisinsk avdeling ved Chiesi dekker den årlige europeiske lungekongressen ERS, denne gangen i Wien. I år har kunstig intelligens kommet med på kongressen med årets kongresstema Mennesker og maskiner: å få riktig balanse. Det er ingen tvil om at KI kan analysere enorme mengder data uten så mye som en kaffepause, men bruk av KI til kliniske beslutninger reiser også spørsmål om etikk og ansvar. Hvem, eller hva, tør du å stole på?
Hvordan høres det ut i en kongresshall når 20 000 lungeinteresserte samles?
Understanding impact of socioeconomic factors on respiratory health
World village session Environmental Health and Inequalities in Respiratory Health Speakers Hanna Haveri, MD, PhD – Neurologist and Planetary Health Physician (Nature Step, Finland) Liz Grant, PhD – Assistant Principal Les mer
Can a podcast make – or break patient engagement?
Podcasts as a tool to support patient participation in hospital consultations: An intervention study Part of the session: Psychological and behavioural dimensions of respiratory innovation Speaker Jannie Frølund (Denmark) In Les mer
Respiratory health, comorbidities and mortality
Global leading researchers —strongly represented by the Nordics—presented compelling findings on chronic obstructive pulmonary disease (COPD) and its complex interplay with cardiovascular, metabolic, genetic, and socioeconomic factors. Les mer
Patients. Do they know enough to take control?
Do patients with greater knowledge manage their disease better? This question was addressed in a cross sectional study presented at ERS2025. Les mer
Body, mind and spirit: Lung conditions are not just somatic
Mental health is inseparable from physical treatment This was the resounding message from a recent international panel moderated by Dr. Liz Steve, a UK-based health psychologist, at the ERS Congress Les mer
Improving outcomes in asthma and COPD through optimized inhaler use
Effective inhaler therapy hinges on matching the right device to the right patient—and ensuring proper technique through training. As sustainability goals evolve, clinical decisions must remain patient-centered to avoid unintended harm. Les mer
Eosinophils in COPD: part of the pattern or misclassified asthma?
Are eosinophils in COPD truly a marker of type 2 (T2) inflammation, or do they simply reflect underlying or misclassified asthma? Les mer
Role of biological sex in asthma and COPD
Women are more affected by asthma in adulthood and increasingly by COPD. Sex hormones influence immune responses in asthma, with estrogen and testosterone affecting inflammation through distinct receptor pathways. Should biological sex guide treatment decisions? Les mer
Redefining Remission in Severe Asthma: A New Framework
A new framework from Professor Celeste Porsbjerg’s team redefines remission in severe asthma by focusing on disease activity, not damage. Early, targeted treatment during the “at-risk asthma” phase may prevent lasting harm. Les mer
Act before damage occurs – early disease in COPD
Some get off to a bad start, others simply do not realize they have a disease. And others fall into the mind trap of thinking that tobacco exposure could be too low to harm. Either way, to identify and treat persons living with COPD early in their disease is intriguing- and possible. Les mer
The exposome and respiratory health: key takeaways from ERS 2025
Lifelong exposure to environmental factors — especially air pollution — significantly affects the risk and progression of chronic lung diseases, and understanding these interactions is key for early intervention and personalized prevention strategies. Les mer
Fighting global threats to respiratory health
Many preventable respiratory hazards are both a cause and a consequence of climate change. Fine particulate matter, especially from wildfires and indoor sources, poses serious health risks and disproportionately affects vulnerable populations. Targeted actions—such as emission reduction, improved indoor air quality, and equity-focused interventions—are essential to protect public health. Les mer
Self-management of asthma
It is essential to understand the beliefs and decisions that drive behavior and decision-making around self-management of asthma. What can influence behaviour and what does ‘Good Control’ look like for the asthma patient – how can self-management be improved? Les mer
Global burden of COPD
COPD is an increasingly important cause of morbidity, disability and mortality worldwide. Environmental risk factors are important to address for future lung health. Les mer
Innovating in rehabilitation
Implementation is one of the greatest challenges in pulmonary rehabilitation of COPD. Innovations in rehabilitation may remove barriers to getting onboard a PR programme - and sticking to it. Les mer
Consequences of vaping and e-cigarette smoking in children and adolescents
Elif Dagli’s talk about e-cigarettes sparked a lot of interest in the Q&A session and it’s clear that we currently have more questions than answers on what risks are entailed and what can be done to stop the trend. Les mer
Lung health starts early
The foetal lungs develop in five different stages before birth, so the timing and type of insults to this development will determine the impact. New data shows that antenatal insults may impact lung function over decades. Les mer
Are all COPD the same?
Spoiler alert: it is not! You are probably not surprised if you are meeting people living with COPD in health care. But are you aware of the pathophysiological differences behind the different faces of this disease? Les mer
Asthma comorbidities
In summary: Asthma is a complex disease worsened by comorbidities like CRSwNP, GERD, OSA, and obesity, which share inflammatory pathways and reduce treatment effectiveness. Obesity, in particular, exacerbates airway inflammation and poor asthma control. A treatable traits approach and multidisciplinary care can improve outcomes by targeting both pulmonary and non-pulmonary factors. Les mer
Preschool wheeze
Preschool wheeze is a heterogenous condition with multiple underlying pathophysiological mechanisms that result in similar clinical manifestations. Frequent severe exacerbations is linked to high risk of developing asthma. Les mer
Let the music play – music therapy as an adjunct to clinical care
Music therapy options, including music listening and singing may address breathlessness, anxiety and depression to boost psychological well-being and motivation to exercise in people with chronic respiratory disease. Les mer
Inhaler Technique – Tricky to Master
Correct inhaler technique is tricky but crucial for treatment of asthma and COPD, as you ensure optimal delivery and deposition of the medication when mastering the device used. Les mer
What is Pulmonary Rehabilitation?
The human body is built for movement, and for people living with COPD, it is particularly important to keep moving, here's why. Les mer
A whole session on research from a primary care perspective!
What is a normal blood eosinophil level and are there quick fixes for improving asthma or COPD control? And can having some who cares make a difference for your health? Les mer
Latest insights on COPD and cardiovascular disease
Summary of symposium Clinical year in review - COPD and cardiovascular disease: latest insights in epidemiology, detection and intervention Speakers: Borja Garcia-Cosio, Sami O. Simons, Bianca Beghè & Jennifer Quint. Les mer
Smoking in patients with obstructive airway diseases: a challenge beyond COPD
Summary of ERS Symposia (September 8, 2024) covering the challenges of adolescent smoking, its harmful effects on asthma and COPD patients, and the reduced effectiveness of treatments in smokers. It highlighted that continued smoking accelerates disease progression, while quitting improves symptoms and treatment outcomes. The key message was the critical need for smoking cessation to promote better long-term health. Les mer
Post-prematurity lung disease: from birth to adulthood
Globally, almost 1 in 10 births are preterm, resulting in 13-15 million preterm babies annually (1). Thankfully, the survival rates have increased dramatically in the last decades. Summary of symposium from Sept 8, 2024. Les mer
Towards health equity in 2050
Health equity is a term referring to fair and just opportunity to maintain optimal health. It entails good conditions for leading healthy lives as well as access to care when in need. Les mer
Digitalisation in health care
Where are we with telehealth in COPD? Potential of telehealth From the talk by Rebecca Disler, Australia, it became clear that telehealth has the potential to add new aspects to Les mer
Biologics in COPD – are we there?
Current status of biologics in COPD In Professor Alberto Papi’s comprehensive lecture on the evolving landscape of biological treatment in COPD, he emphasized the proven efficacy of triple therapy in Les mer
Understanding risk factors of COPD
The understanding of risk factors associated with COPD has advanced over the last 2-3 decades. Can COPD be considered anymore merely as a smoking disease? Or are there other fires Les mer
Mild to moderate asthma – mechanisms and phenotyping
What do I need to know about mild and moderate asthma? Hot topics of asthma in a clinical context were covered by Professor Celeste Porsbjerg (Copenhagen, Denmark) in a presentation Les mer
Digital biomarkers in asthma management
Adherence and health behaviours, can wearables help? Continuous monitoring like never before The growing connectivity in the world provides a substantial potential of digital innovations for management of various diseases Les mer
Next generation evidence-based decision-making in respiratory medicine
SUMMARY: A session exploring how real-life research may aid decision-making and guideline development and complement RCT for better assessment of interventions. Bias, both in randomised controlled trials (RCT) and Real-world Les mer
Longitudinal cohorts in airway disease
Due to the nature of longitudinal studies, the data and learnings obtained are as plenty as they are important and relevant. This became very clear when attending the session covering Les mer
A systematic review of methods of scoring inhaler technique
Inhalation devices: Could we grade individual technique? SUMMARY: A systematic review took a look at how inhalation technique has been assessed in research, finding no standardized method to assess, and Les mer
Burden of tobacco farming and use of electronic nicotine delivery system on the environment and occupational health
SUMMARY: In addition to harmful effects of smoking cigarettes, there are environmental concerns about the complete product life cycle that the tobacco industry is working intensively to downplay. Meanwhile, the Les mer
GOLD guideline evolution: BC is out and Exacerbation prone is in
Reference to presentation: Current challenges in airways disease management – Evolution in GOLD: we cannot ‘see’ ‘C’ anymore and LABA/ICS are gone. Helpful or a hindrance? Speaker: Antonio Anzueto, USA Les mer
Pulmonary rehabilitation in severe and very severe COPD.
Targeting treatable traits in severe chronic obstructive pulmonary disease: a nonpharmacological approach SUMMARY: Pulmonary rehabilitation should be tailor made to improve physical and mental conditions to cope with COPD. It Les mer
Eldre rapporter
Vil du heller lese rapporterne som pdf?
ERS 2024
ERS 2023
ID 7457-11.04.2024